In this episode:Ozempic and Wegovy, both trade names of the drug semaglutide have led a kind of weight loss revolution because of the success patients who use them have had in dropping and keeping off weight. The mechanism by which this drug works does have some consequences for any multisport athletes who use or are considering using it and so on the medical mailbag we look at this drug and what multisport athletes should know. Edward O'Malley is an engineer and age group triathlete who saw a need for a better bike shoe so he designed one himself and the result is the VeloVetta. With its unique closure lever and aerodynamic features the shoe has some real promise for making your transitions and bike splits faster. Meet the man behind the shoe and hear why he did what he did.Segments:[03:53]- Medical Mailbag:[32:52]- Interview: Edward O'Malley LinksEdward's Facebook page @velovetta on Instagram Edward's Website Edward on YouTube

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related